Business JPMorgan Raises Structure Therapeutics Price Target to $105 Structure Therapeutics (NASDAQ: GPCR) received a significant boost in its price target from JPMorgan Chase & Co., which raised it from $65.00 to $105.00... Editorial25 January, 2026